BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 33067636)

  • 1. MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery.
    Rifaioglu AS; Cetin Atalay R; Cansen Kahraman D; Doğan T; Martin M; Atalay V
    Bioinformatics; 2021 May; 37(5):693-704. PubMed ID: 33067636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DeepDTA: deep drug-target binding affinity prediction.
    Öztürk H; Özgür A; Ozkirimli E
    Bioinformatics; 2018 Sep; 34(17):i821-i829. PubMed ID: 30423097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to approach machine learning-based prediction of drug/compound-target interactions.
    Atas Guvenilir H; Doğan T
    J Cheminform; 2023 Feb; 15(1):16. PubMed ID: 36747300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BiComp-DTA: Drug-target binding affinity prediction through complementary biological-related and compression-based featurization approach.
    Kalemati M; Zamani Emani M; Koohi S
    PLoS Comput Biol; 2023 Mar; 19(3):e1011036. PubMed ID: 37000857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DeepPurpose: a deep learning library for drug-target interaction prediction.
    Huang K; Fu T; Glass LM; Zitnik M; Xiao C; Sun J
    Bioinformatics; 2021 Apr; 36(22-23):5545-5547. PubMed ID: 33275143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences.
    Tsubaki M; Tomii K; Sese J
    Bioinformatics; 2019 Jan; 35(2):309-318. PubMed ID: 29982330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BACPI: a bi-directional attention neural network for compound-protein interaction and binding affinity prediction.
    Li M; Lu Z; Wu Y; Li Y
    Bioinformatics; 2022 Mar; 38(7):1995-2002. PubMed ID: 35043942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A deep learning method for drug-target affinity prediction based on sequence interaction information mining.
    Jiang M; Shao Y; Zhang Y; Zhou W; Pang S
    PeerJ; 2023; 11():e16625. PubMed ID: 38099302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations.
    Rifaioglu AS; Nalbat E; Atalay V; Martin MJ; Cetin-Atalay R; Doğan T
    Chem Sci; 2020 Mar; 11(9):2531-2557. PubMed ID: 33209251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GraphDTA: predicting drug-target binding affinity with graph neural networks.
    Nguyen T; Le H; Quinn TP; Nguyen T; Le TD; Venkatesh S
    Bioinformatics; 2021 May; 37(8):1140-1147. PubMed ID: 33119053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDL-CPI: Multi-view deep learning model for compound-protein interaction prediction.
    Wei L; Long W; Wei L
    Methods; 2022 Aug; 204():418-427. PubMed ID: 35114401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A spatial-temporal gated attention module for molecular property prediction based on molecular geometry.
    Li C; Wang J; Niu Z; Yao J; Zeng X
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAPLA: improved prediction of protein-ligand binding affinity by a deep learning approach based on a cross-attention mechanism.
    Jin Z; Wu T; Chen T; Pan D; Wang X; Xie J; Quan L; Lyu Q
    Bioinformatics; 2023 Feb; 39(2):. PubMed ID: 36688724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks.
    Karimi M; Wu D; Wang Z; Shen Y
    Bioinformatics; 2019 Sep; 35(18):3329-3338. PubMed ID: 30768156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest.
    Wu J; Zhang Q; Wu W; Pang T; Hu H; Chan WKB; Ke X; Zhang Y
    Bioinformatics; 2018 Jul; 34(13):2271-2282. PubMed ID: 29432522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DCGAN-DTA: Predicting drug-target binding affinity with deep convolutional generative adversarial networks.
    Kalemati M; Zamani Emani M; Koohi S
    BMC Genomics; 2024 May; 25(1):411. PubMed ID: 38724911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. StackCPA: A stacking model for compound-protein binding affinity prediction based on pocket multi-scale features.
    Lei C; Lu Z; Wang M; Li M
    Comput Biol Med; 2023 Sep; 164():107131. PubMed ID: 37494820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug-target interactions.
    Wan F; Hong L; Xiao A; Jiang T; Zeng J
    Bioinformatics; 2019 Jan; 35(1):104-111. PubMed ID: 30561548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QPoweredCompound2DeNovoDrugPropMax - a novel programmatic tool incorporating deep learning and
    Geoffrey A S B; Madaj R; Valluri PP
    J Biomol Struct Dyn; 2023 Mar; 41(5):1790-1797. PubMed ID: 35007471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A deep learning architecture for metabolic pathway prediction.
    Baranwal M; Magner A; Elvati P; Saldinger J; Violi A; Hero AO
    Bioinformatics; 2020 Apr; 36(8):2547-2553. PubMed ID: 31879763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.